(2022). Systematic approach to outcome assessment from coded electronic healthcare records in the DaRe2THINK NHS-embedded randomized trial . European Heart Journal - Digital Health, 3, 426–436. http://doi.org/https://doi.org/10.1093/ehjdh/ztac046.
(2006). The risk of lymphoma in patients with psoriasis. J Invest Dermatol. http://doi.org/10.1038/sj.jid.5700410.
(2006). Risk of myocardial infarction in patients with psoriasis. Jama. http://doi.org/10.1001/jama.296.14.1735.
(2007). The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol. http://doi.org/10.1001/archderm.143.12.1493.
(2009). The risk of stroke in patients with psoriasis. J Invest Dermatol. http://doi.org/10.1038/jid.2009.112.
(2013). A simple prediction rule for all-cause mortality in a cohort eligible for bariatric surgery. JAMA Surg. http://doi.org/10.1001/jamasurg.2013.3953.
(2014). Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3699.
(2021). Health-care utilization and costs in adults with systemic lupus erythematosus in the United Kingdom: a real-world observational retrospective cohort analysis. Rheumatol Adv Pract. http://doi.org/10.1093/rap/rkab071.
(2021). Disease severity, flares and treatment patterns in adults with systemic lupus erythematosus in the UK: a real-world observational retrospective cohort analysis. Rheumatol Adv Pract. http://doi.org/10.1093/rap/rkab061.